T1	Concept 805 815	amino acid
T2	Concept 816 824	homology
T4	Concept 837 853	modeled proteins
T5	Concept 858 868	SARS-CoV S
T3	Concept 881 884	red
T6	Concept 889 899	amino acid
T7	Concept 900 911	differences
T8	Concept 915 919	blue
T10	Concept 948 953	scale
T11	Concept 939 947	identity
R1	has-property Arg1:T10 Arg2:T11	
R2	in-context Arg1:T2 Arg2:T1	
R3	in-context Arg1:T7 Arg2:T6	
R4	has-property Arg1:T2 Arg2:T3	
R5	in-context Arg1:T2 Arg2:T4	
R6	in-context Arg1:T2 Arg2:T5	
R7	has-property Arg1:T7 Arg2:T8	
R8	in-context Arg1:T7 Arg2:T4	
R9	in-context Arg1:T8 Arg2:T5	
T12	Concept 234 243	2019-nCoV
T13	Concept 244 250	genome
T15	Concept 272 282	similarity
T16	Concept 290 303	2002 SARS-CoV
T17	Concept 304 310	genome
T18	Concept 315 323	proteome
T19	Concept 358 370	interactions
T20	Concept 346 350	many
T21	Concept 387 400	SARS proteome
R10	in-context Arg1:T10 Arg2:T5	
R11	in-context Arg1:T10 Arg2:T4	
T9	Concept 682 691	2019-nCoV
T23	Concept 692 700	3D model
T22	Concept 716 725	2019-nCoV
T24	Concept 730 736	highly
T25	Concept 737 744	similar
T26	Concept 752 775	receptor-binding domain
T27	Concept 777 780	RBD
T28	Concept 792 800	SARS-CoV
R12	has-property Arg1:T22 Arg2:T25	
R13	has-property Arg1:T25 Arg2:T24	
R14	in-context Arg1:T22 Arg2:T26	
R15	in-context Arg1:T26 Arg2:T28	
*	same-as T26 T27
R16	in-context Arg1:T23 Arg2:T9	
R17	entails Arg1:T23 Arg2:T22	
T29	Concept 539 551	convalescent
T30	Concept 552 558	plasma
T31	Concept 559 568	treatment
T32	Action 569 576	reduced
T33	Concept 581 589	hospital
T34	Concept 590 594	stay
T35	Concept 599 608	mortality
T36	Concept 612 620	patients
T37	Concept 626 634	SARS-CoV
T38	Concept 635 644	infection
T39	Concept 649 655	severe
T40	Concept 656 674	influenza A (H1N1)
R18	in-context Arg1:T31 Arg2:T29	
R19	in-context Arg1:T29 Arg2:T30	
R20	subject Arg1:T32 Arg2:T31	
R21	target Arg1:T32 Arg2:T34	
R22	target Arg1:T32 Arg2:T35	
R23	in-context Arg1:T34 Arg2:T33	
R24	has-property Arg1:T36 Arg2:T38	
R25	has-property Arg1:T36 Arg2:T40	
R26	has-property Arg1:T40 Arg2:T39	
R27	in-context Arg1:T38 Arg2:T37	
R28	in-context Arg1:T32 Arg2:T36	
R29	in-context Arg1:T13 Arg2:T12	
T14	Concept 34 39	CD147
T44	Action 67 79	facilitating
T45	Concept 80 88	SARS-CoV
T46	Concept 89 97	invasion
T48	Concept 102 112	host cells
T50	Concept 118 146	CD147-antagonistic peptide-9
T49	Concept 158 170	binding rate
T51	Concept 174 186	HEK293 cells
T52	Concept 205 211	effect
T53	Concept 215 223	SARS-CoV
T54	Concept 153 157	high
R30	has-property Arg1:T49 Arg2:T54	
T55	Concept 194 204	inhibitory
R31	has-property Arg1:T52 Arg2:T55	
R32	in-context Arg1:T52 Arg2:T53	
R33	in-context Arg1:T49 Arg2:T51	
R34	has-property Arg1:T50 Arg2:T49	
R35	has-property Arg1:T50 Arg2:T52	
T56	Concept 437 446	2019-nCoV
T57	Concept 447 455	proteome
R39	subject Arg1:T44 Arg2:T14	
R40	target Arg1:T44 Arg2:T46	
R41	in-context Arg1:T46 Arg2:T45	
R42	in-place Arg1:T44 Arg2:T48	
R38	in-context Arg1:T15 Arg2:T17	
R43	in-place Arg1:T17 Arg2:T16	
R37	in-context Arg1:T15 Arg2:T18	
R44	in-place Arg1:T18 Arg2:T16	
T41	Action 251 259	exhibits
R36	subject Arg1:T41 Arg2:T13	
R45	target Arg1:T41 Arg2:T15	
T42	Action 329 340	hypothesize
R48	in-place Arg1:T19 Arg2:T21	
R49	has-property Arg1:T19 Arg2:T20	
R50	causes Arg1:T41 Arg2:T42	
T47	Action 417 429	be preserved
R51	target Arg1:T47 Arg2:T57	
R52	in-context Arg1:T57 Arg2:T56	
R47	subject Arg1:T47 Arg2:T19	
R46	target Arg1:T42 Arg2:T47	
T43	Reference 326 328	we
R53	subject Arg1:T42 Arg2:T43	
